Workflow
鱼跃医疗(002223) - 2016年8月10日投资者关系活动记录表
YUYUE MEDICALYUYUE MEDICAL(SZ:002223)2022-12-06 10:56

Group 1: Company Performance - The integration of Shanghai Medical Equipment Group is progressing smoothly, with the company returning to normal operations. The revenue for the first half of the year was approximately 300 million, with a net profit of over 30 million, meeting expectations [1] - The employee stock ownership plan was completed in the first half of the year, providing motivation for key personnel within the group [1] Group 2: Product Promotion and Market Demand - The dispersed oxygen machine is targeted for high-altitude areas, with current promotions focused on the Tibet market. There is strong demand from military, government agencies, enterprises, and hotels [2] - The company has completed the installation of oxygen equipment in 22 four-star hotels in Lhasa, which will be fully operational by late August [2] Group 3: Sales and Market Potential - The sleep apnea machine, launched in the second half of 2015, has monthly sales exceeding 1,000 units. In the U.S., the market for sleep apnea machines is larger than that for oxygen machines, but the Chinese market is still in its early stages, showing a trend of continuous growth [2] Group 4: Future Strategy - The company's future strategic direction is clear, focusing on home healthcare, clinical medicine, quality of life, and internet healthcare. Growth will be driven by both organic growth and external acquisitions [2]